Regenerative Medical Technology (RMTG) Debt to Equity (2017 - 2025)
Historic Debt to Equity for Regenerative Medical Technology (RMTG) over the last 9 years, with Q3 2025 value amounting to -$0.56.
- Regenerative Medical Technology's Debt to Equity fell 19309698.34% to -$0.56 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.56, marking a year-over-year decrease of 19309698.34%. This contributed to the annual value of -$0.07 for FY2024, which is 1595838.82% down from last year.
- As of Q3 2025, Regenerative Medical Technology's Debt to Equity stood at -$0.56, which was down 19309698.34% from -$0.1 recorded in Q2 2025.
- Over the past 5 years, Regenerative Medical Technology's Debt to Equity peaked at $0.28 during Q2 2021, and registered a low of -$1.75 during Q4 2021.
- Its 5-year average for Debt to Equity is -$0.31, with a median of -$0.07 in 2025.
- Per our database at Business Quant, Regenerative Medical Technology's Debt to Equity surged by 13988.59% in 2021 and then plummeted by 19309698.34% in 2025.
- Over the past 5 years, Regenerative Medical Technology's Debt to Equity (Quarter) stood at -$1.75 in 2021, then skyrocketed by 99.96% to -$0.0 in 2022, then increased by 29.9% to -$0.0 in 2023, then tumbled by 15958.39% to -$0.07 in 2024, then tumbled by 669.66% to -$0.56 in 2025.
- Its last three reported values are -$0.56 in Q3 2025, -$0.1 for Q2 2025, and -$0.07 during Q1 2025.